Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine

BACKGROUND AND PURPOSE: N-arachidonoyl dopamine (NADA) has complex effects on nociception mediated via cannabinoid CB(1) receptors and the transient receptor potential vanilloid receptor 1 (TRPV1). Anandamide, the prototypic CB(1)/TRPV1 agonist, also inhibits T-type voltage-gated calcium channel cur...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ross, Hamish R, Gilmore, Andrew J, Connor, Mark
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2009
Teme:
Research Papers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697747/
https://ncbi.nlm.nih.gov/pubmed/19226289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2008.00072.x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki